Patent Yard Sign in
Canadian application, no grantCanada

Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector

CA 2405983 A1 · Owner: Kim, Jin Woo · Inventors: Kim, Jin Woo

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention provides a human tumor suppressor protein having the amino acid sequence of SEQ ID NO: 2; a polynucleotide encoding the tumor suppressor protein; an expression vector containing the polynucleotide; a microorganism or animal cell transformed with the expression vector; a method for suppressing proliferation of a cancer cell which comprises introducing the expression vector into a cancer cell to induce apoptosis thereof; and a pharmaceutical composition for preventing or treating cancer which comprises a therapeutically effective amount of the polynucleotide and a pharmaceutically acceptable carrier.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed December 4, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 4, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 4, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 4, 2000
GrantedNo grant recorded
Term endedDecember 4, 2020
Patent numberCA 2405983 A1
Classification (IPC)C12N15/12 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedDec 4, 2000Term endedDec 4, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.